AI in ISO/GMP Environments: Compliance Considerations Before You Deploy

2025-09-24

Executive Summary

• ISO/GMP standards don’t prohibit AI — but they impose specific requirements on how any tool or system used in quality-affecting processes is controlled and documented.
• The risks don’t come from AI itself. They come from deployment approaches: AI without validation, without audit trails, without human review checkpoints — these are real compliance gaps in certified environments.
• Three risk zones to evaluate: document control, quality data and traceability, and decision-making and approvals.
• The appropriate approach: start from lower-risk applications, establish governance before expanding, and ensure AI functions as a support tool for authorized people — not a replacement for them.

The question Quality Directors are actually asking

In many manufacturing businesses today, AI is being deployed from the bottom up: employees start using personal ChatGPT accounts for drafting, department heads use AI to summarize reports, IT pilots a document lookup chatbot.

For an organization without certification requirements, this might be a reasonable and relatively low-risk starting point.

But for an organization maintaining ISO 9001, ISO 22000, GMP, FSSC 22000, or equivalent certification — the question is fundamentally different.

Quality Directors and Compliance Officers need to ask: “In what scope is AI being used? Does it affect the quality management system? If an auditor asks about activities that involved AI, can we answer?”

These questions can’t be sidestepped in a certified environment — and they’re why AI in ISO/GMP businesses cannot be managed with a “just use it and figure it out” approach.

What ISO/GMP requires that bears on AI

Most ISO and GMP standards don’t include specific AI provisions — most were written before AI became common in business operations. But the foundational principles of these standards create clear requirements for any tool or system used in processes with quality implications.

Document control and version management

ISO and GMP standards require rigorous document control: which documents are currently in effect, who has authority to approve changes, and superseded versions must be clearly identified.

When AI participates in creating, modifying, or summarizing documents — particularly SOPs, work instructions, or quality records — the question is whether documents created or edited with AI input go through the standard document control process. Who reviews? Who approves? Which version is currently in effect?

If the answer is “employees use AI to draft, then copy the result into the document system without systematic review” — this is a genuine document control risk.

Traceability and record-keeping

Traceability requirements are at the core of both ISO 22000 and GMP: the ability to trace from finished product back to raw material inputs, production processes, and inspection results.

When AI participates in analyzing quality data, interpreting inspection results, or summarizing batch information — does that output become part of the traceability chain? Or does it exist alongside the official record without being captured?

The answer has a direct impact on the organization’s ability to respond when an auditor asks to reconstruct the decision chain for a specific batch.

System validation requirements

In GMP environments — particularly in pharmaceutical and regulated food contexts — there are requirements for Computer System Validation (CSV) or Computer Software Assurance (CSA): computer systems used in GMP processes need to be validated to demonstrate they function correctly for their intended purpose.

AI systems — particularly when used in data analysis that influences quality decisions — may fall within scope of these requirements, depending on the level of influence and the applicable standard.

This is a specialized area, and organizations should consult compliance advisors with experience in their specific standard before deploying AI into GMP-regulated processes.

Evidence-based decision making

Both ISO 9001 and ISO 22000 include the principle of evidence-based decision making — decisions must be based on verifiable data and evidence.

When AI participates in a decision-making process, this principle applies to the AI’s output: is what AI produces based on specific, identifiable evidence? Can that evidence be reviewed and verified by a person with appropriate authority?

Three risk zones to evaluate

Rather than treating AI in ISO/GMP environments as a single undifferentiated concern, it is more useful to classify applications into three risk zones — each requiring a different approach.

Lower-risk zone — AI supporting individual tasks outside GMP/ISO processes

Examples: drafting internal emails, summarizing documents that are not formal quality records, routine translation, preparing internal presentations.

These applications don’t directly affect quality records, controlled documents, or product-affecting decisions. Compliance risk is low — these can be permitted with basic guidance.

Required governance: Basic AI policy (who can use which tools, what data cannot be entered into external AI tools), but no complex validation requirements.

Medium-risk zone — AI supporting processes with indirect quality influence

Examples: using AI for SOP and procedure lookup, chatbot supporting employees in finding information, AI summarizing inspection reports for faster review.

Here, AI is participating in processes but final decisions remain with authorized people. Compliance risk is moderate — systematic controls are needed.

Required governance: Clear definition of AI’s scope, human review checkpoints before any decision, and explicit documentation that official documents remain the authoritative source (AI supports lookup, it doesn’t replace the original).

Higher-risk zone — AI directly influencing product-affecting decisions

Examples: AI analyzing inspection results to suggest pass/fail determinations, AI synthesizing batch data to support release decisions, AI recommending process parameter changes based on historical data.

In this zone, AI output can directly influence decisions about product safety and compliance. Risk is high — full governance must be in place before deployment.

Required governance: System validation (per applicable standard), complete audit trail for all AI output that influences a decision, mandatory human sign-off with clear documentation, and periodic review of AI performance and accuracy.

The risk isn’t AI — it’s the deployment approach

An important point: ISO/GMP doesn’t prohibit AI. These standards don’t say “don’t use new technology.” They say: any tool or system used in processes with quality implications must be appropriately controlled.

The real risks come from three common deployment patterns:

Pattern 1 — AI in use without organizational clarity on scope. Employees use AI for various tasks, including some that affect quality documentation — but there’s no clear policy, no training, and the Quality Department doesn’t know this is happening.

Pattern 2 — AI output becomes official documentation without systematic review. Someone uses AI to draft a new SOP and the document goes directly into the document management system without going through the standard approval process. The document may contain errors that AI didn’t catch but an experienced reviewer would have.

Pattern 3 — AI participates in compliance-relevant processes without leaving an audit trail. As analyzed in the article on evidence-based AI — this creates a gap in the compliance record even if AI’s output was correct.

A compliance-first approach to AI

There’s no single “deploy AI for ISO” template that works across all organizations and all standards. But there are foundational principles a Quality Director can apply to build an appropriate approach.

Principle 1 — Start from the lower-risk zone. Allow AI in lower-risk applications first — this builds organizational experience with AI in contexts with fewer stakes before expanding into areas requiring more complex governance.

Principle 2 — Build governance before expanding. For each new AI application in the medium or higher-risk zone, define before deployment: what the AI is authorized to do, who reviews and approves AI output, and how the audit trail is generated — not after the fact.

Principle 3 — Keep human authority explicit. In any decision affecting product quality or compliance, the authorized person signs off — AI does not. AI supports analysis and synthesis. This boundary must be clear in documentation and in operational practice.

Principle 4 — Treat AI as a system change. When AI is integrated into a process with compliance requirements, it is a system change — and should go through the organization’s change management process, including risk assessment, staff training, and updating related documentation where needed.

Principle 5 — Distinguish which AI tools are in use.

There is a significant difference between: an employee using personal ChatGPT on a browser (data may be used for model training), using an AI API with data retention controls, and running AI on-premise with no external data sharing. For sensitive data about formulations, processes, or customer information — this distinction has real compliance and data privacy implications.

Conclusion — AI in ISO/GMP is a governance question, not a technology question

AI and ISO/GMP certification can coexist — and when deployed correctly, AI can meaningfully support a quality management system: more efficient audit preparation, better QC data trend analysis, traceability support, and reduced dependence on individual knowledge holders.

But the condition for achieving this is that AI is introduced within a risk management framework — with clear governance, appropriate audit trails, and human authority maintained.

The question isn’t “is AI compatible with ISO/GMP?” — it’s “how is AI being deployed, and does that approach fit the quality management system we’re maintaining?”

Where is your organization in the AI compliance journey?

→ Take the AI Readiness Assessment — includes evaluation of governance and compliance readiness.

Further reading:

• Evidence-Based AI: When the Answer Is Not Enough (previous)
• From AI Hype to Operational AI: A Realistic Roadmap for Manufacturing SMEs (related)
• AI Readiness: Why AI Alone Won’t Make Your Organization More Intelligent (pillar)

This article analyzes AI compliance requirements from a governance and operational perspective, drawing on the principles of ISO 9001, ISO 22000, and GMP. Specific requirements vary significantly by standard, industry, and certification body — particularly for Computer System Validation (CSV/CSA) in pharmaceutical GMP environments. Organizations should consult compliance advisors with expertise in their specific applicable standard before making deployment decisions.